Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The slow delayed rectifier potassium current (IKs) is a fundamental component of the cardiac action potential repolarization process, particularly significant during sympathetic stimulation or increased heart rates [4]. It is mediated by a protein complex consisting of the pore-forming alpha subunit KCNQ1 (Kv7.1) and the regulatory beta subunit KCNE1 (minK) [1, 2]. In rabbit ventricular myocytes, as in humans, IKs provides a critical 'repolarization reserve' that helps maintain electrical stability in the heart under stress [4, 5]. Mutations in the genes encoding these subunits are linked to hereditary Long QT syndromes, specifically LQT1 and LQT5, which predispose individuals to life-threatening arrhythmias [5]. Pharmacological modulation of IKs is a target for anti-arrhythmic therapy, although excessive blockade can lead to pathological prolongation of the QT interval and increased risk of sudden cardiac death [4]. The rabbit model is frequently used in cardiovascular research because its IKs current properties closely mimic those of human ventricular myocytes [4].
Inhibition of the KCNQ1/KCNE1 channel complex reduces the outward potassium current during the plateau phase of the cardiac action potential, thereby prolonging the repolarization phase and increasing the action potential duration [4, 5].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium voltage-gated channel subfamily Q member 1 (KCNQ1) and Potassium voltage-gated channel subfamily E regulatory subunit 1 (KCNE1) complex (IKs).